SpringWorks Price To Sales from 2010 to 2024

SWTX Stock  USD 41.22  1.83  4.65%   
SpringWorks Therapeutics Price To Sales Ratio yearly trend continues to be fairly stable with very little volatility. Price To Sales Ratio is likely to outpace its year average in 2024.
Check SpringWorks Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among SpringWorks Therapeutics' main balance sheet or income statement drivers, such as Interest Expense of 923.7 K, Selling General Administrative of 207.4 M or Total Revenue of 5.2 M, as well as many indicators such as Price To Sales Ratio of 444, Dividend Yield of 0.0 or PTB Ratio of 3.86. SpringWorks financial statements analysis is a perfect complement when working with SpringWorks Therapeutics Valuation or Volatility modules.
  
Check out the analysis of SpringWorks Therapeutics Correlation against competitors.
For more information on how to buy SpringWorks Stock please use our How to Invest in SpringWorks Therapeutics guide.

Latest SpringWorks Therapeutics' Price To Sales Growth Pattern

Below is the plot of the Price To Sales Ratio of SpringWorks Therapeutics over the last few years. Price to Sales Ratio is figured by comparing SpringWorks Therapeutics stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on SpringWorks Therapeutics sales, a figure that is much harder to manipulate than other SpringWorks Therapeutics multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. It is a valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period. SpringWorks Therapeutics' Price To Sales Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in SpringWorks Therapeutics' overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 21.63 X10 Years Trend
Slightly volatile
   Price To Sales Ratio   
       Timeline  

SpringWorks Price To Sales Regression Statistics

Arithmetic Mean153.67
Geometric Mean125.16
Coefficient Of Variation80.12
Mean Deviation93.79
Median89.72
Standard Deviation123.12
Sample Variance15,158
Range354
R-Value0.74
Mean Square Error7,390
R-Squared0.55
Significance0
Slope20.37
Total Sum of Squares212,211

SpringWorks Price To Sales History

2024 444.14
2023 422.99
2021 225.49

About SpringWorks Therapeutics Financial Statements

SpringWorks Therapeutics investors use historical fundamental indicators, such as SpringWorks Therapeutics' Price To Sales, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in SpringWorks Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Price To Sales Ratio 422.99  444.14 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for SpringWorks Stock Analysis

When running SpringWorks Therapeutics' price analysis, check to measure SpringWorks Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SpringWorks Therapeutics is operating at the current time. Most of SpringWorks Therapeutics' value examination focuses on studying past and present price action to predict the probability of SpringWorks Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SpringWorks Therapeutics' price. Additionally, you may evaluate how the addition of SpringWorks Therapeutics to your portfolios can decrease your overall portfolio volatility.